JHEP Reports
@JHEP_Reports
Followers
4,201
Following
64
Media
1,262
Statuses
2,099
JHEP Reports publishes manuscripts concerned with basic, translational and clinical research in the field of hepatology - IF: 8.3
Genève, Suisse
Joined October 2018
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Drake
• 2147010 Tweets
Kendrick
• 1821129 Tweets
Lando
• 496675 Tweets
#GranHermano
• 328823 Tweets
GW最終日
• 264139 Tweets
Furia
• 240211 Tweets
The Heart Part 6
• 126023 Tweets
Mauro
• 123896 Tweets
連休最終日
• 84978 Tweets
Panamá
• 79535 Tweets
Mulino
• 67649 Tweets
REJECT
• 58819 Tweets
NASCAR
• 54695 Tweets
ゴールデンウィーク最終日
• 50391 Tweets
Tom Brady
• 46145 Tweets
Juliana
• 44513 Tweets
Whitney
• 36287 Tweets
Manzana
• 32771 Tweets
Del Moro
• 23849 Tweets
Mother I Sober
• 17517 Tweets
Larson
• 17273 Tweets
ゴムの日
• 16879 Tweets
#RCWIN
• 14266 Tweets
Rial
• 11329 Tweets
#PodemosHablarCHV
• 10295 Tweets
Last Seen Profiles
Pinned Tweet
0
3
11
🆕Patient guideline on
#NALFD
❗️
✅Current knowledge about NAFLD & its management
➡️Developed by patients, patient representatives, clinicians & scientists
➡️Intended to support patients in making informed decisions
#OpenAcces
at👉
#NAFLDsummit
3
98
250
🎉We are thrilled to announce that JHEP Reports has received its VERY FIRST Impact Factor of 9.9 🎉
👏Many thanks to the Editorial Team, our peer reviewers and very innovative authors!
@Zucmanrossi
@EASLnews
@EASLedu
#LiverTwitter
12
29
221
Optimal treatment for small
#HCC
(<3 cm)
➡️Resection,
#livertransplantation
, or locoregional therapy?
🔓
#OpenAccess
at👉
@XiaoWuMD
#LiverTwitter
1
46
89
🆕Review on innovative approaches to the management of
#ascites
in
#cirrhosis
By Florence Wong,
@UofT_DoM
🔓
#OpenAccess
at👉
#LiverTwitter
0
28
86
🆕New review
➡️
#Ammonia
lowering may be a novel therapeutic strategy to control the symptoms and prevent the progression of
#NAFLD
🔓
#OpenAccess
at👉
@AarhusUni
@RajivJalan1
#LiverTwitter
0
29
80
Care of patients with
#liverdisease
during the
#COVID19
pandemic:
@EASLnews
-
@ESCMID
position paper
@EASLedu
@Zucmanrossi
@phil_newsome7
@marumondo
0
67
76
🟪NEW Article in press❕
Preemptive TIPS for the treatment of bleeding from gastric
#fundalvarices
: results of a randomized-controlled trial
🔓
#OpenAccess
at👉
@escorsell
@jaumebosch9
#LiverTwitter
2
35
68
Severity of
#ascites
➡️associated with mortality
In patients with moderate ascites
➡️widely used prognostic
#MELDScore
can predict patient outcomes
🔓
#OpenAccess
at👉
@balcar_lorenz
@salvatore_piano
@ReibergerThomas
#LiverTwitter
0
28
51
Review | Anticoagulation in the cirrhotic patient
#openaccess
#liverdisease
#cirrhosis
@Laura_Turco83
0
35
50
🟪NEW REVIEW❕
What to do about
#HepatocellularCarcinoma
: Recommendations for Health Authorities
➡️An International Liver Cancer Association Advocacy Document
🔓
#OpenAccess
at👉
@allaire_manon
@dice_europe
@ILCAnews
@EuropeLiver
#LiverTwitter
1
30
48
🟪NEW Article in press❕
Predicting Overt
#HepaticEncephalopathy
After Tips: Value Of Three Minimal Hepatic
#Encephalopathy
Tests
🔓
#OpenAccess
at👉
@Maasoumy_lab
#LiverTwitter
0
17
47
Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases
🔓
#OpenAccess
at 👉
#LiverTwitter
#Steatosis
#AutoimmuneHepatitis
0
12
42
Cirrhosis-related sarcopenia may not resolve after liver transplantation
🔓
#OpenAcess
at 👉
#LiverTwitter
2
12
42
🟪NEW Editorial Article❕
The new Editorial Team of JHEP Reports: From successful inception towards an established reputation
🔓
#OpenAcces
at 👉
#LiverTwitter
0
10
46
🟪NEW Review❕
Innovative Approaches to the Management of
#Ascites
in
#Cirrhosis
🔓
#OpenAccess
at👉
By Florence Wong,
@UofT_DoM
#LiverTwitter
0
18
41
❕Preoperative TIPS and in-hospital mortality in patients with cirrhosis undergoing surgery
🔓
#OpenAccess
at 👉
#LiverTwitter
#Cirrhosis
1
18
41
🟪NEW Article in press❕
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of
#hepatocellularcarcinoma
in patients with chronic
#hepatitisB
🔓
#OpenAccess
at👉
#LiverTwitter
1
19
40
Overview of principles of treatment of organ failure in
#ACLF
. Explore the full review with clinical definitions, pathophysiology and updated management of ACLF
#openaccess
at
0
18
37
In Press | Approach to the patient with acute severe
#autoimmune
#hepatitis
by
@KingsCollegeNHS
#liverfailure
0
13
36
🟪NEW Article in press❕
Porto-Sinusoidal Vascular Disorder in Chronic HBV: A Significant Coexistence Not to Be Overlooked
🔓
#OpenAccess
at 👉
@VirginiaHdezGea
#LiverTwitter
0
16
37
🟪NEW Review❕
#HepatitisD
Virus Infection:
✅Pathophysiology
✅Epidemiology
✅Treatment
➡️Report from the first International Delta Cure Meeting 2022
🔓
#OpenAccess
at👉
#LiverTwitter
1
12
37
Review | "Where does
#TIPS
fit in the management of patients with
#cirrhosis
?" by Guadalupe Garcia-Tsao & colleagues
Read Open Access at
@YaleMed
@MedUni_Wien
0
17
34
Vaccination in
#liverdiseases
and
#livertransplantation
➡️Recommendations, implications and opportunities in the post-COVID era
🔓
#OpenAccess
at👉
#LiverTwitter
0
17
34
The
#albumin
-
#bilirubin
(ALBI) score
➡️From
#liverfunction
in patients with
#HCC
to a general measure of liver function
🔓
#OpenAccess
at👉
#LiverTwitter
0
12
35
🆕Article in press❕
Deprescribing zolpidem reduces falls and fractures in patients with
#cirrhosis
By
@ebtapper
& colleagues
🔓
#OpenAcces
at👉
#LiverTwitter
0
13
35
Read about
#ASH
and
#NASH
pathogenesis, treatment and future challenges in this latest review by Alexandre Louvet & colleagues
Open Access at
#liverdisease
0
13
32
❕Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis
🔓
#OpenAccess
at 👉
#LiverTwitter
0
16
34
❕Cardiomyopathy in cirrhosis: From pathophysiology to clinical care
🔓
#OpenAccess
at 👉
#LiverTwitter
0
19
36
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated
#hepatitis
🔓
#OpenAccess
at👉
@juanpabloarab
#LiverTwitter
0
20
35
Assessment criteria for
#HCC
eligibility for liver resection. Read an overview of the indications of liver resection in the management of HCC and the recent advances in
#liversurgery
to improve the
#prognosis
of HCC by
@allaire_manon
& al
#openaccess
0
15
33
#Autoimmunehepatitis
(AIH) is characterised by varied presentations, course of disease and unpredictable treatment response. This review provides a structured practical approach to diagnosing and managing
#AIH
patients.
@MussaratRahim
0
16
31
This review covers
✅tumour immune microenvironment in
#CCA
✅preclinical studies of immunotherapies against CCA
✅clinical trials applying
#immunotherapies
for the treatment of CCA
🔓
#OpenAccess
at👉
#LiverTwitter
0
12
32
Congestive hepatopathy can evolve into
#cirrhosis
&
#HCC
.
Anna Sessa & al. review liver-related complications of congestive hepatopathy & discuss the management and surveillance of these patients.
Read 🔓 open access at
#LiverTwitter
0
14
32
#Hyperammonaemia
in patients with
#cirrhosis
induces
➡️mitochondrial dysfunction
➡️overproduction of
#ReactiveOxygenSpecies
➡️
#celldeath
in primary neurons
🔓
#OpenAccess
at👉
@RajivJalan1
#LiverTwitter
0
16
30
Use of
#albumin
infusion for
#cirrhosis
-related complications
➡️An international position statement
🔓
#OpenAccess
at👉
@dr_NahumMS
#LiverTwitter
1
16
31
🟪NEW Article in press❕
Transplant oncology – Current indications and strategies to advance the field
🔓
#OpenAccess
at 👉
#LiverTwitter
0
12
31
🎉Our new Impact Factor is staying strong at 8.3🎉
👏Many thanks to the Editorial Team, our peer reviewers, and very innovative authors❗️
@Zucmanrossi
@EASLnews
@EASLedu
#LiverTwitter
0
8
30
🟪NEW Article in press❕
Spleen stiffness measurement predicts decompensation and rules out high-risk esophageal varices in primary biliary cholangitis
🔓
#OpenAccess
at 👉
#LiverTwitter
0
12
30
🟪NEW REVIEW❕
#Hepatopulmonary
syndrome
By
@RaevensSarah
et al.
🔓
#OpenAccess
at👉
@UAzMedPhxChair
#Cirrhosis
#PortalHypertension
#LiverTwitter
0
21
29
🟪NEW Article in press❕
Long-term results of
#MycophenolateMofetil
🆚
#azathioprine
use in patients with
#AutoimmuneHepatitis
🔓
#OpenAccess
at👉
#LiverTwitter
0
16
30
🟪NEW Article in press❕
Intrapancreatic fat deposition is unrelated to liver steatosis in metabolic dysfunction-associated steatotic liver disease
🔓
#OpenAccess
at 👉
#LiverTwitter
#MASLD
@annelindemak
0
7
31
🟪NEW Article in press❕
Ultra-processed food consumption and non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance: a systematic review
🔓
#OpenAccess
at 👉
#NAFLD
#MetabolicSyndrome
#InsulinResistance
#LiverTwitter
0
10
28
The environment’s stiffness modulates the phenotype of healthy and cirrhotic liver cells by altering the nuclear morphology through cytoskeleton-derived mechanical forces.
#cirrhosis
@JSGracia
,
@docberza
@jaumebosch9
@SergiGuixe
0
11
28
We are delighted to announce that
@JHEP_Reports
has been accepted for indexing in
#PubMed
Central after less than one year of publication.
Read more here:
@EASLedu
@JHepatology
#openaccess
@Zucmanrossi
@tgustot
0
9
29
Therapeutic management of
#COVID19
according to the etiology of liver
#cirrhosis
& complications in a high-volume hepatology center.
Read the full protocol at
@EASLnews
0
11
29
Read the most talked-about JHEP Reports articles in 2020 based on number of mentions.🥇 with 222 mentions: "Approach to the patient with acute severe
#autoimmune
#hepatitis
" 🔓Open access at
✍️
@MussaratRahim
,
@MichaelHenegha8
& Rosa Miquel
#livertwitter
1
11
28
A new study reported that liver dysfunction biomarkers (prolonged PT/INR and aPTT, decreasing factor V activity) should not be used to assess bleeding risk in patients with
#cirrhosis
. Alternative biomarkers need to be developed.
#thrombosis
@CHUVLausanne
0
16
27
In our July issue❕
Global
#hemostatic
profiling in patients with decompensated
#cirrhosis
and bacterial infections
🔓
#OpenAccess
at👉
@a_zanetto
#LiverTwitter
0
17
28
Overview of the main genetic alterations, clinical, histological and pathological and radiological features as well the treatment available of cHCC-CCA. Explore more on rare primary
#LiverCancer
in a recent review by
@NaultJc
,
@maximeronot
, & al.
@EASLnews
1
15
27
📌In our March issue
CT-derived liver and spleen volume accurately diagnose clinically significant
#portalhypertension
in patients with
#hepatocellularcarcinoma
🔓
#OpenAccess
at👉
@luistevilla
@salonsol_
#LiverTwitter
1
11
27
Severity of
#ascites
➡️associated with mortality
In patients with moderate ascites
➡️widely used prognostic
#MELDScore
can predict patient outcomes
🔓
#OpenAccess
at👉
@balcar_lorenz
@salvatore_piano
@ReibergerThomas
#LiverTwitter
0
12
27
🟪NEW Review❕
Optimal Treatment for Small
#HCC
(<3 cm):
Resection,
#LiverTransplantation
, or Locoregional Therapy?
🔓
#OpenAccess
at👉
@XiaoWuMD
#LiverTwitter
0
13
27
Autoimmune hepatitis is characterized by varied clinical presentations and unpredictable treatment responses. This review provides a structured practical approach for diagnosing & managing of
#AIH
patients.
Open access at
#livertwitter
@MichaelHenegha8
0
15
27
In this review,
@Dr_Ampuero
and
@mromerogomez
suggest strategies to integrate comorbidities in
#NAFLD
patients, as well as the impact of the lifestyle, to develop personalized therapeutic approaches. Explore more
#openaccess
at
#clinicaltrial
0
10
27
🟪NEW Article in press❕
Radiological diagnosis of hepatocellular carcinoma does not preclude biopsy before treatment
🔓
#OpenAccess
at 👉
#LiverTwitter
0
9
25
📢 The new JHEP Reports team already started working on October 1st. A retreat organized with the previous team was instrumental in designing the action plan for 2024-2028.
@EASLnews
@idibaps
@hospitalclinic
0
1
26
Comparison of the current international guidelines on the management of
#hepatocellularcarcinoma
#liverdisease
#livercancer
#EBM
#OpenAccess
0
15
25
The identification of patients with advanced
#liverdisease
in large
#NAFLD
population remains an unmet challenge.
@JeromeBoursier
& Emmanuel Tsochatzis discuss populations & lesions to target and current screening strategies.
Read 🔓 open access at
0
13
26
📌In our March issue
Recurrence of initial disease in patients transplanted for
#NAFLD
#cirrhosis
➡️frequent & rapid
➡️Grade ≥2 steatosis at 1 year highly predictive of recurrence of NASH & advanced
#fibrosis
🔓
#OpenAccess
at👉
@CHUdeLyon
#LiverTwitter
1
9
26
❕Liver transplant selection criteria and outcomes in critically ill patients with ACLF
🔓
#OpenAccess
at 👉
#LiverTwitter
0
14
26
Data in this study suggest
✅
#hyperammonaemia
significantly decreases cortical
#oxygenation
➡️potentially compromising brain energy metabolism
🔓
#OpenAccess
at👉
@AHadjihambi
#hepaticencephalopathy
#LiverTwitter
1
14
25
🟪NEW Article in press❕
Infections Increase The Risk Of Decompensation And Death In Patients With Early Alcohol-Related Liver Disease
🔓
#OpenAccess
at 👉
#LiverTwitter
0
10
25
🟪NEW Article in press❕
Risk of further decompensation/mortality in patients with
#cirrhosis
and
#ascites
as the first single decompensation event
🔓
#OpenAcces
at👉
#LiverTwitter
0
9
25
Enhancing interventions for prevention of mother-to-child- transmission of
#hepatitisB
virus
🔓
#OpenAccess
at👉
@pippa_matt
#LiverTwitter
0
18
25
❕Radiological diagnosis of hepatocellular carcinoma does not preclude biopsy before treatment
🔓
#OpenAccess
at 👉
#LiverTwitter
#HCC
0
10
27
New Review "Case finding strategies in non-alcoholic fatty liver disease" by
@JeromeBoursier
& Emmanuel Tsochatzis.
Read 🔓 Open access at
#NAFLD
#livertwitter
0
13
24
🟪NEW Article in press❕
Real-world evidence on non-invasive tests and associated cut-offs used to assess
#fibrosis
in routine clinical practice
🔓
#OpenAccess
at👉
@JVLazarus
#LiverTwitter
0
14
24
An impaired pituitary–adrenal signalling axis in stable
#cirrhosis
is linked to worse prognosis
🔓
#OpenAccess
at👉
@ReibergerThomas
#LiverTwitter
0
11
24
Review | Historical narrative from
#fattyliver
in the nineteenth century to contemporary
#NAFLD
– Reconciling the present with the past
Read 🔓 open access at
#livertwitter
@GutLiver
2
10
24
Congestive hepatopathy can evolve into
#cirrhosis
&
#HCC
.
Anna Sessa & al. review liver-related complications of congestive hepatopathy & discuss the management and surveillance of these patients.
Read 🔓 open access at
#LiverTwitter
0
12
24
Data in this study suggest
✅
#hyperammonaemia
significantly decreases cortical
#oxygenation
➡️potentially compromising brain energy metabolism
🔓
#OpenAccess
at👉
@AHadjihambi
#hepaticencephalopathy
#LiverTwitter
0
13
24
🟪NEW Review❕
#Nonalcoholicfattyliver
disease in Women – Current Knowledge and Emerging Concepts
🔓
#OpenAccess
at👉
#LiverTwitter
0
6
24
🟪NEW Article in press❕
Low
#HDLcholesterol
levels predict
#hepatocellularcarcinoma
development in individuals with
#liverfibrosis
🔓
#OpenAccess
at👉
#LiverTwitter
0
12
24
🟪NEW Article in press❕
Increased sinusoidal pressure impairs liver endothelial mechanosensing, uncovering novel biomarkers of
#PortalHypertension
🔓
#OpenAccess
at👉
@MartiOR92
@JSGracia
#LiverTwitter
1
9
24
Liver steatosis is a strong predictor of mortality and
#cancer
in chronic
#hepatitisB
regardless of viral load
#NASH
#NAFLD
#HBV
#openaccess
0
19
23
🟪NEW Article in press❕
Clinical pattern of checkpoint inhibitor-induced
#liverinjury
in a multicenter cohort
🔓
#OpenAccess
at👉
@thibault_comont
@LucyMeunier66
#LiverTwitter
0
9
24
🟪NEW Review in press❕
The
#Albumin
-
#Bilirubin
score: from
#liverfunction
in patients with
#HCC
to a general measure of liver function
🔓
#OpenAccess
at👉
#LiverTwitter
0
14
23
🟪NEW Review❕
Vaccination in
#liverdiseases
&
#livertransplantation
:
➡️Recommendations, implications and opportunities in the post-covid era
🔓
#OpenAccess
at👉
By Maria Pilar Ballester,
@RajivJalan1
&
@drgautammehta
#LiverTwitter
0
13
23
What is the cellular origin of
#HCC
❓
@KirkWangensteen
& colleagues review data on
✅the cells of origin in
#RegeneratingLiver
& HCC
✅the implications of these findings for prevention & treatment
#OpenAcces
at👉
#LiverTwitter
0
8
22
We are really proud to announce that our first articles are now available online!
Check them here:
#LiverDisease
@Zucmanrossi
@tgustot
@EASLnews
1
12
23
🟪NEW Review out❕
Understanding the cellular interactome of non-alcoholic fatty liver disease
🔓
#OpenAcces
at👉
#LiverTwitter
#NAFLD
0
8
23
🟪NEW Article in press❕
Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure and mortality
🔓
#OpenAccess
at 👉
#LiverTwitter
0
7
23
🟪NEW Article in press❕
#Hyperammonemia
induces mitochondrial dysfunction and neuronal
#CellDeath
🔓
#OpenAccess
at👉
@RajivJalan1
#LiverTwitter
0
7
23
Review | Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment
#ACLF
#DecompensatedCirrhosis
#inflammatoryresponse
0
10
22
#Cholangiocarcinoma
(CCA) is a highly fatal cancer that arises in up to 20% of patients with
#PSC
. Current detection methods have suboptimal sensitivity and/or specificity.
@GuroLind
& al summarize promising DNA methylation biomarkers for CCA detection.
0
8
22
In Press | Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment
#ACLF
#DecompensatedCirrhosis
#inflammatoryresponse
0
13
22
🟪NEW Article in press❕
The burden of non-alcoholic
#steatohepatitis
: A systematic review of health-related quality of life and patient-reported outcomes
🔓
#OpenAcces
at👉
#LiverTwitter
1
11
22
The
#albumin
-
#bilirubin
(ALBI) score
➡️From
#liverfunction
in patients with
#HCC
to a general measure of liver function
🔓
#OpenAccess
at👉
#LiverTwitter
0
6
21
Treatment responses and outcomes in patients with
#autoimmunehepatitis
and concomitant features of
#nonalcoholicfattyliverdisease
🔓
#OpenAccess
at👉
#LiverTwitter
0
13
22
❕Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality
🔓
#OpenAccess
at 👉
#LiverTwitter
0
9
21
We are delighted to announce that
@JHEP_Reports
has been accepted for indexing in
#PubMed
Central after less than one year of publication.
Read more here:
@EASLedu
@JHepatology
#openaccess
0
4
21
Review | Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment
#ACLF
#DecompensatedCirrhosis
#inflammatoryresponse
1
9
21
🟪NEW Article in press❕
Distinct hepatocyte identities in
#liverhomeostasis
and regeneration
🔓
#OpenAccess
at👉
#LiverTwitter
0
3
21
🟪NEW Article in press❕
Hepatic venous pressure gradient in sinusoidal obstruction syndrome: diagnostic value and link with histological lesions
🔓
#OpenAccess
at👉
@RautouE
#HPVG
#PortalHypertension
#LiverBiopsy
#LiverTwitter
1
7
21
What is new regarding diagnosis & management of
#HepatopulmonarySyndrome
❓
✅This review summarises current knowledge & understanding of pathogenesis based on experimental models & translational studies
🔓
#OpenAccess
at👉
@RaevensSarah
#LiverTwitter
0
6
21
What is the cellular origin of
#HCC
❓
@KirkWangensteen
& colleagues review data on
✅the cells of origin in
#RegeneratingLiver
& HCC
✅the implications of these findings for prevention & treatment
#OpenAcces
at👉
#LiverTwitter
1
10
20
“Non-alcoholic fatty liver disease (NAFLD) is the most prevalent
#liverdisease
worldwide, and a major cause of liver
#cirrhosis
and hepatocellular carcinoma” Read this free to access review
0
13
20
❕Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis
🔓
#OpenAccess
at 👉
#LiverTwitter
0
7
20